MedPath

The Effect of Selenium Supplement on subclinical Hypothyroidism in childre

Phase 3
Recruiting
Conditions
Subclinical hypothyroidism.
Subclinical iodine-deficiency hypothyroidism
Registration Number
IRCT20220314054284N1
Lead Sponsor
Gorgan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
148
Inclusion Criteria

Children with subclinical hypothyroidism
Age 3- 16 years

Exclusion Criteria

Dissatisfaction with participating in the study
Failure to follow the patient
Lack of patient medication compliance by parents

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The amount of changes in the level of primary variables (TSH). Timepoint: Sections for measuring thyroid hormone levels (TSH) before the intervention and 3 months after (as soon as the treatment period ends). Method of measurement: Comparison of the effect of selenium supplementation on the reduction of TSH level.;The amount of changes in the level of primary variables (selenium). Timepoint: Sections for measuring of selenium level before the intervention and 3 months after (as soon as the treatment period ends). Method of measurement: Comparison of the effect of selenium supplementation on selenium changes.;The amount of changes in the level of primary variables of FT4. Timepoint: Sections for measuring of FT4 level before the intervention and 3 months after (as soon as the treatment period ends). Method of measurement: Comparison of the effect of selenium supplementation on the reduction of T FT4 level.
Secondary Outcome Measures
NameTimeMethod
Changes in the body's metabolism. Timepoint: Before and 3 months after the start of the intervention. Method of measurement: Evaluation of weight, improvement of patient symptoms including constipation, fatigue, appetite, brittle nails and hair loss, etc.
© Copyright 2025. All Rights Reserved by MedPath